Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
Clinical trial NCT06383559 · RECRUITING
Trial details
- NCT number
- NCT06383559
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-07-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.